Tag: AMD
- Sep 26th, 2024
Are You at Risk for Wet AMD? Key Factors to Consider
Wet AMD is a serious condition that can cause permanent vision loss if left untreated. Therefore, it’s important to take steps to reduce your risk and see a retina specialist regularly.
- Sep 13th, 2024
Dry AMD and Vision Loss: Early Detection and Prevention Tips
Dry age-related macular degeneration (AMD) is a common eye condition that is a leading cause of central vision loss in adults 60 years of age and older.
- May 23rd, 2024
Living with Geographic Atrophy: Coping Strategies and Treatment
Navigating life with geographic atrophy demands a proactive approach that involves embracing adaptive strategies, connecting with a retina specialist, and exploring the latest treatment options.
- Dec 28th, 2023
A Closer Look at Drusen: Understanding the Impact on Vision
Drusen are small yellow deposits that build up in the back of the eye and can be seen by your ophthalmologist during a dilated eye exam.
- Oct 30th, 2023
Digital Eye Strain: How to Protect Your Retina in the Digital Age
Can blue light from digital screens cause damage to the retina or contribute to diseases like age-related macular degeneration (AMD)? Learn about how blue light impacts vision.
- Aug 18th, 2023
5 Facts About Wet Age-Related Macular Degeneration
Wet age-related macular degeneration is a severe condition, requiring regular monitoring. The more information you have, the sooner you can alert your retina specialist.
- Jul 28th, 2023
Age-Related Macular Degeneration: Preventive Measures for High-Risk Individuals
Various age-related macular degeneration risk factors are controllable. Discuss lifestyle changes with a retinal specialist, and learn how to slow AMD and safeguard your vision.
- Jun 30th, 2023
Top 5 Risk Factors for Age-Related Macular Degeneration
If you’re 50 years or older, you’re probably familiar with age-related macular degeneration (AMD). While you can’t avoid the passage of time, some risk factors can be effectively managed.
- Apr 3rd, 2023
FDA Approves New Medication for Geographic Atrophy
The FDA has approved Syfovre™, the first and only treatment for geographic atrophy. A damaging, blinding, final phase of dry AMD, it afflicts over 1 million Americans.
- Mar 28th, 2023
The First Ever Treatment for Geographic Atrophy Is Now Available
There's amazing news for the more than one million Americans afflicted with geographic atrophy-Syfovre™ (pegcetacoplan injection) was recently approved by the US Food and Drug Administration (FDA).